Minerva Endocrinology
Scope & Guideline
Exploring New Horizons in Endocrine Research
Introduction
Aims and Scopes
- Endocrine Disorders and Diseases:
The journal focuses on a wide array of endocrine disorders, including thyroid diseases, diabetes, obesity, and reproductive endocrine issues, providing insights into their pathophysiology, diagnosis, and management. - Clinical Studies and Real-World Data:
Minerva Endocrinology publishes clinical studies, including real-world data analyses, that evaluate treatment efficacy, patient outcomes, and the impact of various interventions on endocrine health. - Molecular and Genetic Research:
The journal includes research on the molecular and genetic underpinnings of endocrine disorders, exploring areas such as genetic mutations, epigenetics, and biomarker discovery. - Nutritional and Lifestyle Interventions:
There is a significant emphasis on the role of nutrition and lifestyle changes in managing endocrine conditions, particularly obesity and diabetes, highlighting the importance of holistic treatment approaches. - Innovative Therapeutic Approaches:
The journal explores novel therapeutic strategies, including pharmacological treatments, nutraceuticals, and surgical interventions, aimed at improving patient care in endocrinology.
Trending and Emerging
- Nutraceuticals and Endocrine Health:
There is a growing interest in the role of nutraceuticals in managing endocrine disorders, especially concerning fertility, obesity, and metabolic diseases, highlighting the importance of dietary interventions alongside traditional treatments. - Telemedicine and Digital Health:
The COVID-19 pandemic has accelerated research into telemedicine and digital health solutions for managing endocrine disorders, indicating a shift towards more accessible healthcare delivery models. - Precision Medicine in Endocrinology:
Emerging research is focusing on precision medicine approaches, utilizing genetic and molecular profiling to tailor treatments for individual patients with endocrine disorders, particularly in diabetes and thyroid cancer. - Impact of COVID-19 on Endocrine Disorders:
The intersection of COVID-19 and endocrine health is a rapidly expanding area of research, exploring how the pandemic affects patients with pre-existing endocrine conditions, as well as the implications for treatment and management. - Integration of Lifestyle Medicine:
There is an increasing emphasis on integrating lifestyle medicine into the management of endocrine disorders, promoting comprehensive strategies that address physical activity, nutrition, and behavioral health.
Declining or Waning
- Traditional Endocrine Testing:
Research focusing solely on traditional diagnostic methods for endocrine disorders, such as basic hormone level assessments, is becoming less prevalent as the field shifts towards more comprehensive and integrative approaches. - Generalized Obesity Studies:
While obesity remains a core area, the focus on generalized studies without specific interventions or personalized approaches is waning, reflecting a shift towards more targeted research that explores individual variability in treatment responses. - Aging and Endocrinology:
Research specifically linking aging with endocrine dysfunction seems to be less emphasized compared to the broader discussions surrounding obesity and metabolic syndrome, indicating a possible shift in research priorities. - Basic Descriptive Studies in Diabetes:
There is a noticeable decline in basic descriptive studies on diabetes prevalence and incidence, as the journal increasingly prioritizes studies that offer insights into innovative management strategies and molecular mechanisms. - Historical Perspectives on Endocrine Treatments:
Papers focusing on historical perspectives or reviews of past treatments for endocrine disorders are less common, suggesting a trend towards contemporary and forward-thinking research.
Similar Journals
Journal of the ASEAN Federation of Endocrine Societies
Empowering Collaboration: Uniting Endocrine Experts in Southeast AsiaWelcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.
Annals of Pediatric Endocrinology & Metabolism
Unlocking insights for a healthier future in child endocrinology.Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Bridging Experimental and Clinical EndocrinologyEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.
JOURNAL OF ENDOCRINOLOGY
Transforming Knowledge into Practice in EndocrinologyJOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.
CLINICAL ENDOCRINOLOGY
Innovating diagnostics and treatments for endocrine disorders.CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.
Turkish Journal of Endocrinology and Metabolism
Connecting Researchers to Transform Endocrinology PracticesThe Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.
Archives of Endocrinology Metabolism
Empowering discovery in the realm of hormones and metabolism.Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.
Hormones-International Journal of Endocrinology and Metabolism
Pioneering Insights into Diabetes and Metabolic DisordersHormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.
Acta Endocrinologica-Bucharest
Fostering collaboration in the endocrine community.Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.
ENDOCRINE PATHOLOGY
Innovative Insights into Endocrine DisordersENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.